Howard Lee is of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 147,777 shares of AMPH, which is worth approximately $5.78 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 579 shares (Common Stock) at a price of $42.04 per share, resulting in proceeds of $24,341. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 148K
0% 3M change
1.72% 12M change
Total Value Held $5.78 Million

Howard Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
SELL
Payment of exercise price or tax liability
$24,341 $42.04 p/Share
579 Reduced 0.39%
147,777 Common Stock
Jun 03 2024
BUY
Grant, award, or other acquisition
-
3,076 Added 2.03%
148,356 Common Stock
Jun 10 2023
SELL
Payment of exercise price or tax liability
$17,126 $45.67 p/Share
375 Reduced 0.26%
145,280 Common Stock
Jun 05 2023
BUY
Grant, award, or other acquisition
-
2,716 Added 1.83%
145,655 Common Stock
Jun 01 2023
SELL
Open market or private sale
$750,888 $45.02 p/Share
16,679 Reduced 10.45%
142,939 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
$278,372 $16.69 p/Share
16,679 Added 9.46%
159,618 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
4,163 Added 2.83%
142,939 Common Stock
Jun 06 2022
SELL
Open market or private sale
$388,897 $37.79 p/Share
10,291 Reduced 6.9%
138,776 Common Stock
Jun 06 2022
BUY
Exercise of conversion of derivative security
$176,079 $17.11 p/Share
10,291 Added 6.46%
149,067 Common Stock
May 23 2022
SELL
Open market or private sale
$349,300 $34.93 p/Share
10,000 Reduced 6.72%
138,776 Common Stock
May 23 2022
BUY
Exercise of conversion of derivative security
$171,100 $17.11 p/Share
10,000 Added 6.3%
148,776 Common Stock
Jun 12 2021
SELL
Payment of exercise price or tax liability
$3,127 $19.92 p/Share
157 Reduced 0.11%
138,776 Common Stock
Jun 08 2021
SELL
Open market or private sale
$154,480 $19.31 p/Share
8,000 Reduced 5.44%
138,933 Common Stock
Jun 08 2021
BUY
Exercise of conversion of derivative security
$131,440 $16.43 p/Share
8,000 Added 5.16%
146,933 Common Stock
Jun 07 2021
SELL
Open market or private sale
$150,905 $19.28 p/Share
7,827 Reduced 5.56%
132,914 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$128,598 $16.43 p/Share
7,827 Added 5.27%
140,741 Common Stock
Jun 07 2021
BUY
Grant, award, or other acquisition
-
6,019 Added 4.15%
138,933 Common Stock
May 20 2021
SELL
Open market or private sale
$197,400 $19.74 p/Share
10,000 Reduced 7.0%
132,914 Common Stock
May 20 2021
BUY
Exercise of conversion of derivative security
$164,300 $16.43 p/Share
10,000 Added 6.54%
142,914 Common Stock
HL

Howard Lee

Rancho Cucamonga,, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH